BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sandlund J, Bartolome A, Almazan A, Tam S, Biscocho S, Abusali S, Bishop JJ, Nolan N, Estis J, Todd J, Young S, Senchyna F, Banaei N. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology. J Clin Microbiol 2018;56:e00908-18. [PMID: 30158195 DOI: 10.1128/JCM.00908-18] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Pettengill MA. Hindsight Is 2019-the Year in Clinical Microbiology. Clin Microbiol Newsl 2020;42:87-92. [PMID: 32461708 DOI: 10.1016/j.clinmicnews.2020.05.002] [Reference Citation Analysis]
2 Hansen G, Young S, Wu AHB, Herding E, Nordberg V, Mills R, Griego-Fullbright C, Wagner A, Ong CM, Lewis S, Yoon J, Estis J, Sandlund J, Friedland E, Carroll KC. Ultrasensitive Detection of Clostridioides difficile Toxins in Stool by Use of Single-Molecule Counting Technology: Comparison with Detection of Free Toxin by Cell Culture Cytotoxicity Neutralization Assay. J Clin Microbiol 2019;57:e00719-19. [PMID: 31434724 DOI: 10.1128/JCM.00719-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Orenstein R, Patron RL. Clostridioides difficile therapeutics: guidelines and beyond. Ther Adv Infect Dis 2019;6:2049936119868548. [PMID: 31448117 DOI: 10.1177/2049936119868548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Shah MD, Balada-Llasat JM, Coe K, Reed E, Sandlund J, Pancholi P. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results. J Clin Microbiol 2020;58:e01681-19. [PMID: 32051264 DOI: 10.1128/JCM.01681-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sandlund J, Davies K, Wilcox MH. Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy. J Clin Microbiol 2020;58:e01913-19. [PMID: 32269098 DOI: 10.1128/JCM.01913-19] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, du Toit B, Fredericks ES, Lekalakala-Mokaba MR, Maluleka C, Rajabally MN, Reubenson G, Shuping L, Swart K, Swe Han KS, Wadula J, Wojno J, Lowman W. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. S Afr J Infect Dis 2020;35:219. [PMID: 34485483 DOI: 10.4102/sajid.v35i1.219] [Reference Citation Analysis]
7 Boly FJ, Reske KA, Kwon JH. The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities. Curr Infect Dis Rep 2020;22:7. [PMID: 33762897 DOI: 10.1007/s11908-020-0715-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sandlund J, Wilcox MH. Ultrasensitive Detection of Clostridium difficile Toxins Reveals Suboptimal Accuracy of Toxin Gene Cycle Thresholds for Toxin Predictions. J Clin Microbiol 2019;57:e01885-18. [PMID: 30944188 DOI: 10.1128/JCM.01885-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
9 Sandlund J, Estis J, Katzenbach P, Nolan N, Hinson K, Herres J, Pero T, Peterson G, Schumaker JM, Stevig C, Warren R, West T, Chow SK. Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests. J Clin Microbiol 2019;57:e00945-19. [PMID: 31434726 DOI: 10.1128/JCM.00945-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Landry ML, Topal JE, Estis J, Katzenbach P, Nolan N, Sandlund J. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing. J Clin Microbiol 2020;58:e01629-19. [PMID: 31776192 DOI: 10.1128/JCM.01629-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hitchcock MM, Holubar M, Hogan CA, Tompkins LS, Banaei N. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes. J Clin Microbiol 2019;57:e01288-19. [PMID: 31511334 DOI: 10.1128/JCM.01288-19] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sullivan KV. Advances in Diagnostic Testing that Impact Infection Prevention and Antimicrobial Stewardship Programs. Curr Infect Dis Rep 2019;21:20. [PMID: 31044313 DOI: 10.1007/s11908-019-0676-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Lenggenhager L, Zanella MC, Poncet A, Kaiser L, Schrenzel J. Discordant Clostridioides difficile diagnostic assay and treatment practice: a cross-sectional study in a tertiary care hospital, Geneva, Switzerland. BMJ Open 2020;10:e036342. [PMID: 32928850 DOI: 10.1136/bmjopen-2019-036342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]